Clinical Trial Update: Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy [Phase 2, Phase 3]

View source ↗

Summary

This ClinicalTrials.gov entry reports a Phase 2/3 trial evaluating perhexiline for myocardial protection in left ventricular hypertrophy, with endpoints related…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Hypertrophy
• Myocardial Reperfusion Injury

Drugs mentioned

• Perhexiline (perhexiline)

Snippet

Sponsor: University Hospital Birmingham | Conditions: Myocardial Reperfusion Injury, Cardiac Output, Low | Phase 2, Phase 3 | Status: UNKNOWN